• Users Online: 108
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2022  |  Volume : 9  |  Issue : 3  |  Page : 419-430

Nanopolyphenols: Perspective on oxidative stress-induced diseases


MGMIHS OMICS Research Center, MGM Central Research Laboratory, MGM Medical College and Hospital, and Department of Medical Biotechnology, MGM School of Biomedical Sciences, MGM Institute of Health Sciences (Deemed to be University), Navi Mumbai, Maharashtra, India

Correspondence Address:
Dr. Raman P Yadav
MGMIHS OMICS Research Center, MGM Central Research Laboratory, MGM Medical College and Hospital, and Department of Medical Biotechnology, MGM School of Biomedical Sciences, MGM Institute of Health Sciences (Deemed to be University), Navi Mumbai 410209, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mgmj.mgmj_100_22

Rights and Permissions

Recently nanopolyphenols are gaining widespread interest in the drug discovery domain. Nanonization of polyphenols has greatly affected the therapeutic index owing to improvement in pharmacokinetic and biopharmaceutical obstacles linked with the use of natural polyphenols. They have been looking at an emerging paradigm for an array of disease symptoms. In this article, we have explored the therapeutic potential of nanopolyphenols in oxidative stress-induced diseases such as neurodegeneration, cancer, obesity, and diabetes. This article will present the current state of the art of various nanopolyphenols targeting oxidative stress-induced diseases. The advanced fabrication strategies presented for polyphenols including nanocrystal, mesoporous silica nanoparticles, nanoparticles, nanoliposome, gold nanoparticle, and nanosuspension are discussed. The information presented in light of recent in vitro, in vivo, and clinical evidence for nanoformulation and delivery of polyphenols may show a new dimension to future research in the realm of herbal therapy for oxidative stress-induced diseases. Significant information on the molecular mechanisms underlying linkages of oxidative stress with neurodegenerative diseases, cancer, obesity, and diabetes is discussed. Valuable information on dietary polyphenols in these diseases and their clinical data is presented. Based on different experimental evidence, the review findings support phenomenal therapeutic strategies for nanopolyphenolic fabrication with extended benefits and a condensed time frame. The status of clinical trials conducted on nanopolyphenols is presented. Although clinical trials conducted on nanopolyphenols for mentioned diseases are few, we have tried to present as much available clinical data in this article.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed136    
    Printed12    
    Emailed0    
    PDF Downloaded29    
    Comments [Add]    

Recommend this journal